APA (7th ed.) Citation

Niemeyer, P., Laute, V., Zinser, W., Becher, C., Kolombe, T., Fay, J., . . . Fickert, S. (2019). A prospective, randomized, open-label, multicenter, phase III noninferiority trial to compare the clinical efficacyy of matrix-associated autologous chondrocyte implantation with spheroid technology versus arthroscopic microfracture for cartilage defects of the knee. Orthopaedic journal of sports medicine, 7(7), . https://doi.org/10.1177/2325967119854442

Chicago Style (17th ed.) Citation

Niemeyer, Philipp, Volker Laute, Wolfgang Zinser, Christoph Becher, Thomas Kolombe, Jakob Fay, Stefan Klaus Pietsch, and Stefan Fickert. "A Prospective, Randomized, Open-label, Multicenter, Phase III Noninferiority Trial to Compare the Clinical Efficacyy of Matrix-associated Autologous Chondrocyte Implantation with Spheroid Technology Versus Arthroscopic Microfracture for Cartilage Defects of the Knee." Orthopaedic Journal of Sports Medicine 7, no. 7 (2019). https://doi.org/10.1177/2325967119854442.

MLA (9th ed.) Citation

Niemeyer, Philipp, et al. "A Prospective, Randomized, Open-label, Multicenter, Phase III Noninferiority Trial to Compare the Clinical Efficacyy of Matrix-associated Autologous Chondrocyte Implantation with Spheroid Technology Versus Arthroscopic Microfracture for Cartilage Defects of the Knee." Orthopaedic Journal of Sports Medicine, vol. 7, no. 7, 2019, https://doi.org/10.1177/2325967119854442.